Disturbance of systemic antioxidant profile in nonsmall cell lung carcinoma

European Respiratory Journal

Volumn 29, Issue 2, 2007, Pages 273-278

  Ho, J C ^a   Chan Yeung, M ^a   Ho, S P ^a   Mak, J C ^a   Ip, M S ^a   Ool, G C ^a   Wong, M P ^a   Tsang, K W ^a   Lam, W K ^a  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

Catalase; Glutathione peroxidase; Lung cancer; Superoxide dismutase

Indexed keywords

ANTIOXIDANT; CATALASE; GLUTATHIONE PEROXIDASE; SUPEROXIDE DISMUTASE;

ADULT; AGED; ANTIOXIDANT ACTIVITY; ARTICLE; BLOOD SAMPLING; CANCER STAGING; CHINESE; CONTROLLED STUDY; ERYTHROCYTE; FEMALE; HUMAN; HUMAN CELL; LUNG NON SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; PREDICTION; PRIORITY JOURNAL; SMOKING HABIT; SPECTROPHOTOMETRY;

ADULT; AGED; ANTIOXIDANTS; ASIAN CONTINENTAL ANCESTRY GROUP; CARCINOMA, NON-SMALL-CELL LUNG; CATALASE; CELL TRANSFORMATION, NEOPLASTIC; ERYTHROCYTES; FEMALE; GLUTATHIONE PEROXIDASE; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM STAGING; OXIDOREDUCTASES; SUPEROXIDE DISMUTASE;

EID: 33846904094     PISSN: 09031936     EISSN: None     Source Type: Journal    
DOI: 10.1183/09031936.00000106     Document Type: Article

References (37)

1. Cerutti PA. Prooxidant states and tumor promotion. Science 1985; 227: 375-381.
2. Patel RP, Levonen A, Crawford JH, Darley-Usmar VM. Mechanisms of the pro- and anti-oxidant actions of nitric oxide in atherosclerosis. Cardiovasc Res 2000; 47: 465-474.
3. Seidman MD, Quirk WS, Shirwany NA. Reactive oxygen metabolites, antioxidants and head and neck cancer. Head Neck 1999; 21: 467-479.
4. 2. J Appl Physiol 1993; 75: 1256-1262.
5. Putnam CD, Arvai AS, Bourne Y, Tainer JA. Active and inhibited human catalase structures: ligand and NADPH binding and catalytic mechanism. J Mol Biol 2000; 296: 295-309.
6. Brennan P, Fortes C, Butler J, et al. A multicenter case-control study of diet and lung cancer among non-smokers. Cancer Causes Control 2000; 11: 49-58.
7. The effect of vitamin E and beta carotene on the incidence of lung cancer and other cancers in male smokers. The Alpha-Tocopherol, Beta Carotene Cancer Prevention Study Group. N Engl J Med 1994; 330: 1029-1035.
8. Omenn GS, Goodman GE, Thornquist MD, et al. Risk factors for lung cancer and for intervention effects in CARET, the Beta-Carotene and Retinol Efficacy Trial. J Natl Cancer Inst 1996; 88: 1550-1559.
9. Ho JC, Zheng S, Comhair SA, Farver C, Erzurum SC. Differential expression of manganese superoxide dismutase and catalase in lung cancer. Cancer Res 2001; 61: 8578-8585.
10. Hristozov D, Gadjeva V, Vlaykova T, Dimitrov G. Evaluation of oxidative stress in patients with cancer. Arch Physiol Biochem 2001; 109: 331-336.
11. Greene FL, Page DL, Fleming ID, et al., eds. American Joint Committee on Cancer Staging Manual. 6th Edn. New York, Springer, 2002.
12. Aebi H. Catalase in vitro. Methods Enzymol 1984; 105: 121-126.
13. Paglia DE, Valentine WN. Studies on the quantitative and qualitative characterization of erythrocyte glutathione peroxidase. J Lab Clin Med 1967; 70: 158-169.
14. Gromadzinska J, Wasowicz W, Rdyzynski K, Szeszenia-Dabrowska N. Oxidative-stress markers in blood of lung cancer patients occupationally exposed to carcinogens. Biol Trace Elem Res 2003; 91: 203-215.
15. Kumagai Y, Pi JB, Lee S, et al. Serum antioxiclant vitamins and risk of lung and stomach cancers in Shenyang, China. Cancer Lett 1998; 129: 145-149.
16. Martin-Mateo MC, Molpeceres LM, Ramos G. Assay for erythrocyte superoxide dismutase activity in patients with lung cancer and effects on pollution and smoke trace elements. Biol Trace Elem Res 1997; 60: 215-226.
17. Kaynar H, Meral M, Turhan H, Keles M, Celik G, Akcay F. Glutathione peroxidase, glutathione-S-transferase, catalase, xanthine oxidase, Cu-Zn superoxide dismutase activities, total glutathione, nitric oxide, and malondialdehyde levels in erythrocytes of patients with small cell and non-small cell lung cancer. Cancer Lett 2005; 227: 133-139.
18. Shimoda-Matsubayashi S, Matsumine H, Kobayashi T, Nakagawa-Hattori Y, Shimizu Y, Mizuno Y. Structural dimorphism in the mitochondrial targeting sequence in the human manganese superoxide dismutase gene. A predictive evidence for conformational change to influence mitochondrial transport and a study of allelic association in Parkinson's disease. Biochem Biophys Res Commun 1996; 226: 561-565.
19. Forsberg L, Lyrenas L, de Faire U, Morgenstern R. A common functional C-T substitution polymorphism in the promoter region of the human catalase gene influences transcription factor binding, reporter gene transcription and is correlated to blood catalase levels. Free Radic Biol Med 2001; 30: 500-505.
20. Erhola M, Nieminen MM, Kellokumpu-Lehtinen P, et al. Effects of surgical removal of lung cancer on total plasma antioxidant capacity in lung cancer patients. J Exp Clin Cancer Res 1998; 17: 219-225.
21. Ballaz S, Mulshine JL. The potential contributions of chronic inflammation to lung carcinogenesis. Clin Lung Cancer 2003; 5: 46-62.
22. Parafiniuk M, Czerwinski F, Parafiniuk W. Vascular changes and inflammatory infiltrations in primary lung cancers. Patol Pol 1989; 40: 293-309.
23. Talwar D, Ha TK, Scott HR, et al. Effect of inflammation on measures of antioxidant status in patients with non-small cell lung cancer. Am J Clin Nutr 1997; 66: 1283-1285.
24. Islam KN, Kayanoki Y, Kaneto H, et al. TGF-β1 triggers oxidative modifications and enhances apoptosis in HIT cells through accumulation of reactive oxygen species by suppression of catalase and glutathione peroxidase. Free Radic Biol Med 1997; 22: 1007-1017.
25. Hirose K, Longo DL, Oppenheim JJ, Matsushima K. Overexpression of mitochondrial manganese superoxide dismutase promotes the survival of tumor cells exposed to interleukin-1, tumor necrosis factor, selected anticancer drugs, and ionizing radiation. FASEB J 1993; 7: 361-368.
26. Kuninaka S, Ichinose Y, Koja K, Toh Y. Suppression of manganese superoxide dismutase augments sensitivity to radiation, hyperthermia and doxorubicin in colon cancer cell lines by inducing apoptosis. Br J Cancer 2000; 83: 928-934.
27. Kosenko EA, Kaminsky YuG,, Stavrovskaya IG, Sirota TV, Kondrashova MN. The stimulatory effect of negative air ions and hydrogen peroxide on the activity of superoxide dismutase. FEBS Lett 1997; 410: 309-312.
28. Liu CS, Chen HW, Lii CK, Tsai CS, Kuo CL, Wei YH. Alterations of plasma antioxidants and mitochondrial DNA mutation in hair follicles of smokers. Environ Mol Mutagen 2002; 40: 168-174.
29. Wei W, Kim Y, Boudreau N. Association of smoking with serum and dietary levels of antioxidants, in adults: NHANES III, 1988-1994. Am J Public Health 2001; 91: 258-264.
30. Alberg AJ, Chen JC, Zhao H, Hoffman SC, Comstock GW, Helzlsouer KJ. Household exposure to passive cigarette smoking and serum micronutrient concentrations. Am J Clin Nutr 2000; 72: 1576-1582.
31. Polidori MC, Mecocci P, Stahl W, Sies H. Cigarette smoking cessation increases plasma levels of several antioxidant micronutrients and improves resistance towards oxidative challenge. Br J Nutr 2003; 90: 147-150.
32. Lykkesfeldt J, Christen S, Wallock LM, Chang HH, Jacob RA, Ames BN. Ascorbate is depleted by smoking and repleted by moderate supplementation: a study in male smokers and nonsmokers with matched dietary antioxidant intakes. Am J Clin Nutr 2000; 71: 530-536.
33. Dietrich M, Block G, Norkus EP, et al. Smoking and exposure to environmental tobacco smoke decrease some plasma antioxidants and increase γ-tocopherol in vivo after adjustment for dietary antioxidant intakes. Am J Clin Nutr 2003; 77: 160-166.
34. Tsuchiya M, Asada A, Kasahara E, Sato EF, Shindo M, Inoue M. Smoking a single cigarette rapidly reduces combined concentrations of nitrate and nitrite and concentrations of antioxidants in plasma. Circulation 2002; 105: 1155-1157.
35. Hulea SA, Olinescu R, Nita S, Crocnan D, Kummerow FA. Cigarette smoking causes biochemical changes in blood that are suggestive of oxidative stress: a case-control study. J Environ Pathol Toxicol Oncol 1995; 14: 173-180.
36. Lam KY, Fu KH, Wong MP, Wang EP. Significant changes in the distribution of histologic types of lung cancer in Hong Kong. Pathology 1993; 25: 103-105.
37. Devesa SS, Shaw GL, Blot WJ. Changing patterns of lung cancer incidence by histologic type. Cancer Epidemiol Biomarkers Prev 1991; 1: 29-34.